Research Article
Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score
Figure 1
ROC curve of pretreatment dNLR in assessment of the tumor progression rate at 6th month. ROC: receiver operator characteristic; dNLR: derived neutrophil-to-lymphocyte.